DNMT3B and prostate carcinoma: Multiple studies showed that DNMT3B acted as an oncogene in tumorigenesis, including acute myeloid leukemia (Wong et al., 2019), gastric cancer (Li et al., 2016), bladder cancer (Liu et al., 2020), and prostate cancer (Zhu et al., 2020).